Medulloblastoma – pipeline review, h2 2012


Published on

Aarkstore Enterprise || Medulloblastoma – Pipeline Review, H2 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Medulloblastoma – pipeline review, h2 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Medulloblastoma – Pipeline Review, H2 2012RSS link of Global Markets DirectSummaryGlobal Markets Direct’s, Medulloblastoma - Pipeline Review, H2 2012, provides anoverview of the Medulloblastoma therapeutic pipeline. This report providesinformation on the therapeutic development for Medulloblastoma, complete withlatest updates, and special features on late-stage and discontinued projects. It alsoreviews key players involved in the therapeutic development for Medulloblastoma.Medulloblastoma - Pipeline Review, H2 2012 is built using data and informationsourced from Global Markets Direct’s proprietary databases, Company/Universitywebsites, SEC filings, investor presentations and featured press releases fromcompany/university sites and industry-specific third party sources, put together byGlobal Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Medulloblastoma.- A review of the Medulloblastoma products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  2. 2. therapeutics.Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Medulloblastoma Overview 6Therapeutics Development 7An Overview of Pipeline Products for Medulloblastoma 7Medulloblastoma Therapeutics under Development by Companies 9Medulloblastoma Therapeutics under Investigation by Universities/Institutes 10Late Stage Products 12Comparative Analysis 12Mid Clinical Stage Products 13Comparative Analysis 13Early Clinical Stage Products 14Comparative Analysis 14Discovery and Pre-Clinical Stage Products 15Comparative Analysis 15Medulloblastoma Therapeutics – Products under Development by Companies 16Medulloblastoma Therapeutics – Products under Investigation byUniversities/Institutes 17Companies Involved in Medulloblastoma Therapeutics Development 18Novartis AG 18Pfizer Inc. 19Lixte Biotechnology Holdings, Inc. 20Archer Biosciences, Inc 21Medulloblastoma – Therapeutics Assessment 22Assessment by Monotherapy Products 22Assessment by Combination Products 23Assessment by Route of Administration 24Assessment by Molecule Type 26Drug Profiles 28CST-102 - Drug Profile 28
  3. 3. Sodium Thiosulfate - Drug Profile 29ARC-100 - Drug Profile 30GW572016 - Drug Profile 32List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012 Review, H22012&PubId=&pagenum=1Nasopharyngeal Cancer – Pipeline Review, H2 2012Medulloblastoma – Pipeline Review, H2 2012Ewing Sarcoma – Pipeline Review, H2 2012Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H2 2012Equine Encephalitis – Pipeline Review, H2 2012Anaplastic Astrocytoma – Pipeline Review, H2 2012Penile Cancer – Pipeline Review, H2 2012Natural Killer Cell Lymphomas – Pipeline Review, H2 2012
  4. 4. Medullary Thyroid Cancer – Pipeline Review, H2 2012Fever – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: